This message was sent to ##Email##
|
|
|
|
|
| |
| HEALTH CARE NEWS AND UPDATES |
ACS
The John Muir Health Rectal Cancer Program, based in Walnut Creek and Concord, Calif., is the nation’s first to earn accreditation from the National Accreditation Program for Rectal Cancer (NAPRC), a program launched last year and administered by the American College of Surgeons (ACS).
READ MORE
ACS
The first findings from a collaborative study within the American College of Surgeons (ACS) Cancer Programs — and published today in the Journal of the American Medical Association (JAMA) — showed no significant association between frequency of surveillance testing and the time to detection of recurrence for colorectal cancer patients.
READ MORE
|
Promoted by
|
|
|
|
 |
Oncology Nurse Advisor
Oncology advanced practice provider (APP)-run clinics may fill a void for patients with cancer receiving ambulatory oncologic management who require urgent evaluation and treatment, according to findings presented at the 2018 Oncology Nursing Society (ONS) Annual Congress. There are a lot of therapies that were traditionally given on the inpatient side of care that are being moved to outpatient settings,” said Suzanne McGettigan, MSN, CRNP, ANP-BC, AOCN, “which is further limiting the ability to add additional patients on for urgent visits.”
READ MORE
Medscape
Very few of the heavy smokers who are eligible for lung cancer screening in the United States have undergone such screening, a nationwide analysis has found.
The US Preventive Services Task Force (USPSTF) recommended in 2013 that all individuals aged 55 to 80 years who have a smoking history of 30 pack-years or longer and who currently smoke or have quit within the past 15 years should be screened annually for lung cancer with low-dose CT (LDCT).
READ MORE
Stat News
Tara Soumerai writes: Most doctors and health policy experts these days are focused on the overabundance of pills fueling the opioid crisis gripping the United States. Cancer doctors like me lie awake at night worrying about the looming shortage of injectable opioids that we need to treat our in-pain and dying patients.
READ MORE
 |
|
Our ihcDirect® method yields a revolutionary technology that opens a spectrum of new clinical applications including intraoperative surgery. Using the Novodiax PolyHRP technology, Intraoperative IHC tests can now be completed in just 10 minutes using fresh frozen tissues.
For more details, see our
 ihcDirect® product list.
|
|
Nature
Cancer has been a late bloomer in the microbiome revolution that has surged through biomedicine. Over the past few decades, scientists have linked the gut’s composition of microbes to dozens of seemingly unrelated conditions — from depression to obesity. Cancer has some provocative connections as well: inflammation is a contributing factor to some tumours and a few types of cancer have infectious origins. But with the explosive growth of a new class of drug — cancer immunotherapies — scientists have been taking a closer look at how the gut microbiome might interact with treatment and how these interactions might be harnessed.
READ MORE
|
Promoted by
|
|
|
|
 |
MedPage Today
Cancer patients receiving chemotherapy randomized to follow a prescribed walking program for six months had lower glycemic levels and improved treatment symptoms, compared to a control group receiving information about exercise benefits, according to a small study presented here.
READ MORE
Medical News Today
After tumor removal surgery, treatment with erectile dysfunction drugs and a flu vaccine may help to stop the cancer returning. These drugs, aided by the flu vaccine, remove a block to the immune system that can sometimes result from cancer surgery and also give it a boost.
READ MORE
 |
|
Donate now to help Doctors Without Borders bring emergency medical care where it is needed most. Doctors Without Borders USA relies on unrestricted donations from private donors so when an emergency strikes we assess the needs and can act fast.
Donate today.
|
|
Forbes
Researchers from the National Cancer Institute have discovered a new way by which breast cancer cells lie dormant after spreading, before starting to grow again, causing metastatic disease.
The study published recently in the journal Nature Communications uses a mouse model of breast cancer to show how cells that spread to the lungs can remain dormant before starting to divide again, forming metastatic tumors, which are often incredibly hard to treat. Whilst in this dormant state, the research reveals that the breast cancer cells use a process called autophagy to survive, which essentially means they can break down worn-out cell components that might ultimately limit their ability to divide and grow into tumors, replacing these with recycled parts.
READ MORE
| ACS CANCER PROGRAMS UPDATES |
ACS
The 2018 ACS Cancer Programs Annual Conference: Learn. Interact. Transform. will be held in Chicago on September 5-7. This is the only conference developed by the American Joint Committee on Cancer (AJCC), Commission on Cancer (CoC), American College of Surgeons Clinical Research Program (ACS CRP), National Accreditation Program for Breast Centers (NAPBC), National Accreditation for Rectal Cancer (NAPRC), and National Cancer Database (NCDB). The program will provide information on the issues impacting health care treating patients with cancer. To have your name added to the conference mailing, please complete the information request form. Plan now to attend this important event. Coming soon — information on the 2018 Call for Posters!
#ACSCANCER CONFERENCE
READ MORE
American College of Surgeons - NAPRC
The National Accreditation Program for Rectal Cancer (NAPRC) is now accepting applications. The NAPRC was developed to ensure that rectal cancer patients receive appropriate care following a multidisciplinary approach. Programs will be evaluated on the standards and metrics outlined in The National Accreditation Program for Rectal Cancer Standards Manual 2017 (revised October 2017).
READ MORE
Introduction and Descriptors for the 8th Edition : Please join the American Joint Committee on Cancer for a free webinar on Introduction and Descriptors for the 8th Edition Cancer Staging Manual. The webinar will be held on Thursday, May 31 from 1-2 p.m. CDT. Donna Gress, RHIT, CTR, will facilitate the webinar. In this webinar you will learn how to:
- Demonstrate purpose and approach to AJCC staging
- Outline use of stage descriptors and guidelines
- Dissect 8th Edition 1-page guide
Register here.
ACS-CRP
The Commission on Cancer (CoC) initiated a pilot study at 20 CoC-accredited facilities in the fall of 2017 as a component of the Comparison of Operative to Monitoring and Endocrine Therapy (COMET) clinical trial (PIs: Drs. Shelley Hwang, Ann Partridge, Alastair Thompson). The study examines the risks and benefits of active surveillance compared with usual care for patients diagnosed with low risk ductal carcinoma in situ (DCIS), commonly known as stage 0 breast cancer. The pilot study concluded Jan. 1, 2018. Following data analysis, a CoC Special Study will be launched in spring 2018 to investigate outcomes from DCIS treatment retrospectively.
READ MORE
| IMPORTANT DATES AND DEADLINES |
| Date |
Event |
Location |
| June 1 |
Call for Data closes
|
|
| July 21-24 |
ACS Quality and Safety Conference
|
Orlando, FL
|
| Sept. 5-7 |
2018 Cancer Programs Conference
|
Chicago, IL
|
| Oct. 21-25 |
ACS Clinical Congress
|
Boston, MA
|
|
Missed last week's issue? See which articles your colleagues read most.
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
The Brief
Connect with AJCC
Connect with CoC
Connect with NAPBC
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Cancer Programs do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the authors and not of the American College of Surgeons, and the Cancer Programs.
American College of Surgeons
633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
